Case Report: Successful use of emapalumab in adult B-cell acute lymphoblastic leukemia experiencing severe neurotoxicity and hemophagocytic lymphohistiocytosis-like features after CAR-T cell therapy.

Manghisi B, Cotilli G, Fedele M, Perfetti P, Terruzzi E, Verga L, Borin LM, Carrer A, Fumagalli M, Ferrari MB, Moretti A, Rona R, Benini A, Vergnano B, Palumbo G, Zincone A, Maglia O, Scollo C, Steidl C, Iovino L, Balduzzi A, Piazza R, Gambacorti-Passerini C, Parma M, Aroldi A

Open source

DOI: 10.3389/fimmu.2025.1563736
Published: 2025
Container: Frontiers in immunology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2025.1563736,
  title = {Case Report: Successful use of emapalumab in adult B-cell acute lymphoblastic leukemia experiencing severe neurotoxicity and hemophagocytic lymphohistiocytosis-like features after CAR-T cell therapy.},
  author = {Manghisi B and Cotilli G and Fedele M and Perfetti P and Terruzzi E and Verga L and Borin LM and Carrer A and Fumagalli M and Ferrari MB and Moretti A and Rona R and Benini A and Vergnano B and Palumbo G and Zincone A and Maglia O and Scollo C and Steidl C and Iovino L and Balduzzi A and Piazza R and Gambacorti-Passerini C and Parma M and Aroldi A},
  year = {2025},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2025.1563736},
  url = {https://doi.org/10.3389/fimmu.2025.1563736}
}

RIS

TY  - JOUR
TI  - Case Report: Successful use of emapalumab in adult B-cell acute lymphoblastic leukemia experiencing severe neurotoxicity and hemophagocytic lymphohistiocytosis-like features after CAR-T cell therapy.
AU  - Manghisi B
AU  - Cotilli G
AU  - Fedele M
AU  - Perfetti P
AU  - Terruzzi E
AU  - Verga L
AU  - Borin LM
AU  - Carrer A
AU  - Fumagalli M
AU  - Ferrari MB
AU  - Moretti A
AU  - Rona R
AU  - Benini A
AU  - Vergnano B
AU  - Palumbo G
AU  - Zincone A
AU  - Maglia O
AU  - Scollo C
AU  - Steidl C
AU  - Iovino L
AU  - Balduzzi A
AU  - Piazza R
AU  - Gambacorti-Passerini C
AU  - Parma M
AU  - Aroldi A
PY  - 2025
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2025.1563736
UR  - https://doi.org/10.3389/fimmu.2025.1563736
ER  -

APA

B, M., G, C., M, F., P, P., E, T., L, V., LM, B., A, C., M, F., MB, F., A, M., R, R., A, B., B, V., G, P., A, Z., O, M., C, S., C, S., L, I., A, B., R, P., C, G., M, P., & A, A. (2025). Case Report: Successful use of emapalumab in adult B-cell acute lymphoblastic leukemia experiencing severe neurotoxicity and hemophagocytic lymphohistiocytosis-like features after CAR-T cell therapy.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2025.1563736

Source records

pubmed · retrieved 2026-09-26T06:26:09.915Z
europe-pmc · retrieved 2026-09-26T06:26:09.932Z